China Pharma Holdings (CPHI) Return on Sales (2010 - 2026)

China Pharma Holdings' Return on Sales history runs 17 years deep, the most recent figure standing at 0.01% for Q1 2026.

• Quarterly Return on Sales changed 0.0% year-over-year to 0.01% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.01% (changed 0.0% YoY) and the FY2025 annual result came in at 0.01%, changed 0.0% from the prior year.
• Return on Sales was 0.01% for Q1 2026 at China Pharma Holdings, down from 0.01% in the prior quarter.
• Across five years, Return on Sales topped out at 0.0% in Q1 2023 and bottomed at 0.02% in Q2 2024.
• A 5-year average of 0.01% and a median of 0.01% in 2022 frame the typical range for Return on Sales.
• Annual changes were most pronounced in 2024 — Return on Sales fell 1 bps — and 2025, when it grew 1 bps.
• China Pharma Holdings' Return on Sales stood at 0.0% in 2022, then sank by 32 bps to 0.01% in 2023, then tumbled by 88 bps to 0.01% in 2024, then increased by 8 bps to 0.01% in 2025, then dropped by 17 bps to 0.01% in 2026.
• Business Quant data shows CPHI's Return on Sales at 0.01% in Q1 2026, 0.01% in Q4 2025, and 0.01% in Q3 2025.